These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 14977454)

  • 1. Clinical case presentation: therapeutic challenges in adolescent-onset bipolar disorder.
    Coffey B
    J Child Adolesc Psychopharmacol; 2003; 13(4):425-30. PubMed ID: 14977454
    [No Abstract]   [Full Text] [Related]  

  • 2. Case of bipolar disorder successfully stabilized with clonazepam, valproate and lithium after numerous relapses for 47 years.
    Mashiko H; Kurita M; Shirakawa H; Ohtomo K; Hashimoto M; Miyashita N; Niwa S
    Psychiatry Clin Neurosci; 2004 Jun; 58(3):340-1. PubMed ID: 15149305
    [No Abstract]   [Full Text] [Related]  

  • 3. Aripiprazole efficacy in irritability and disruptive-aggressive symptoms: young mania rating scale line analysis from two, randomized, double-blind, placebo-controlled trials.
    Frye MA; Eudicone J; Pikalov A; McQuade RD; Marcus RN; Carlson BX
    J Clin Psychopharmacol; 2008 Apr; 28(2):243-5. PubMed ID: 18344741
    [No Abstract]   [Full Text] [Related]  

  • 4. Divalproex for the treatment of aggression associated with adolescent mania.
    DelBello MP; Adler C; Strakowski SM
    J Child Adolesc Psychopharmacol; 2004; 14(2):325-8. PubMed ID: 15319029
    [No Abstract]   [Full Text] [Related]  

  • 5. Resolution of haloperidol-induced hyperprolactinemia with aripiprazole.
    Lorenz RA; Weinstein B
    J Clin Psychopharmacol; 2007 Oct; 27(5):524-5. PubMed ID: 17873694
    [No Abstract]   [Full Text] [Related]  

  • 6. [Manic syndrome: diagnostic trends and principles of treatment].
    Hardy-Baylé MC
    Rev Prat; 1998 Apr; 48(7):805-9. PubMed ID: 11767379
    [No Abstract]   [Full Text] [Related]  

  • 7. Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial.
    Sachs GS; Vanderburg DG; Karayal ON; Kolluri S; Bachinsky M; Cavus I
    J Clin Psychiatry; 2012 Nov; 73(11):1412-9. PubMed ID: 23218157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of quetiapine XR and divalproex-associated neutropenia followed by successful use of ziprasidone.
    Estabrook KR; Pheister M
    J Clin Psychopharmacol; 2012 Jun; 32(3):417-8. PubMed ID: 22561473
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and safety of combination of risperidone and haloperidol with divalproate in patients with acute mania.
    Ouyang WC; Hsu MC; Yeh IN; Kuo CC
    Int J Psychiatry Clin Pract; 2012 Sep; 16(3):178-88. PubMed ID: 22404731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of aggression in patients with bipolar disorder.
    Swann AC
    J Clin Psychiatry; 1999; 60 Suppl 15():25-8. PubMed ID: 10418811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exacerbation of psychotic disorder during pregnancy in the context of medication discontinuation.
    Wakil L; Perea E; Penaskovic K; Stuebe A; Meltzer-Brody S
    Psychosomatics; 2013; 54(3):290-3. PubMed ID: 23218063
    [No Abstract]   [Full Text] [Related]  

  • 12. Addition of lamotrigine to valproic acid: a successful outcome in a case of rapid-cycling bipolar affective disorder.
    da Rocha FF; Soares FM; Correa H; Teixeira AL
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1548-9. PubMed ID: 17630063
    [No Abstract]   [Full Text] [Related]  

  • 13. Introduction: the use of mood stabilizers in the treatment of psychiatric disorders.
    Bowden CL
    J Clin Psychiatry; 1999; 60 Suppl 5():3-4. PubMed ID: 10192401
    [No Abstract]   [Full Text] [Related]  

  • 14. Much improved outcome with gabapentin-divalproex combination in adults with bipolar disorders and developmental disabilities.
    Hellings JA
    J Clin Psychopharmacol; 2006 Jun; 26(3):344-6. PubMed ID: 16702908
    [No Abstract]   [Full Text] [Related]  

  • 15. Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder.
    Post RM; Altshuler LL; Frye MA; Suppes T; Keck PE; McElroy SL; Leverich GS; Luckenbaugh DA; Rowe M; Pizzarello S; Kupka RW; Grunze H; Nolen WA
    J Clin Psychiatry; 2010 Sep; 71(9):1176-86; quiz 1252-3. PubMed ID: 20923622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Methodological approach to inter "guideline" variability in the management of bipolar disorders].
    Samalin L; Llorca PM
    Encephale; 2012 Apr; 38(2):126-32. PubMed ID: 22516270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bipolar disorder.
    Geddes J
    Clin Evid; 2005 Jun; (13):1158-81. PubMed ID: 16135292
    [No Abstract]   [Full Text] [Related]  

  • 18. Adjunctive treatment of manic agitation with lorazepam versus haloperidol: a double-blind study.
    Lenox RH; Newhouse PA; Creelman WL; Whitaker TM
    J Clin Psychiatry; 1992 Feb; 53(2):47-52. PubMed ID: 1541605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute mania: haloperidol dose and augmentation with lithium or lorazepam.
    Chou JC; Czobor P; Charles O; Tuma I; Winsberg B; Allen MH; Trujillo M; Volavka J
    J Clin Psychopharmacol; 1999 Dec; 19(6):500-5. PubMed ID: 10587284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methodologies to avoid the enrollment of ineligible patients in clinical trials.
    Tohen M
    J Clin Psychiatry; 2012 Nov; 73(11):1426-7. PubMed ID: 23218159
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.